Immediate oxygen delivery
Support microvascular and tissue-level oxygen delivery when anemia, blood loss or red-cell limitations reduce effective oxygen transport.
BHOC Product
A Biological Hemoglobin Oxygen Carrier platform.
BHOC is a veterinary and multi-species development direction within Precision Oxygen Therapeutics.
BHOC
Biological Hemoglobin Oxygen Carrier
Product identity
Beyond the red blood cell system and its limitations.
BHOC means Biological Hemoglobin Oxygen Carrier. It is a cell-free hemoglobin oxygen-delivery platform designed for immediate, controlled microvascular and tissue-level oxygenation when red-cell-dependent oxygen delivery is insufficient, delayed or operationally constrained, while endogenous erythropoiesis recovers.
The intended product profile is donor-independent, designed to be red-cell-antigen-free and compatible across blood types, with long shelf life and practical room-temperature logistics. By moving oxygen delivery beyond dependence on intact donor red cells, BHOC is designed to address limitations created by blood-group matching, donor availability, storage, transport, expiry and access.
Across species, blood-group systems may be known, partially characterized or unknown. BHOC uses one core cell-free oxygen-carrier architecture intended to avoid red-cell blood-group antigens, while species-specific formulation, dosing, safety and efficacy remain independent evidence requirements.
BHOC is not intended to reproduce every biological function of whole blood. Its core objective is more precise: preserve or restore effective oxygen delivery to tissues and cells when the red-cell system cannot provide it adequately or quickly enough.
Development profile
The intended product profile.
Beyond blood-group barriers
A donor-independent, red-cell-antigen-free development profile designed to avoid dependence on blood typing, donor matching and crossmatching.
Room-temperature logistics
Long shelf life, practical storage and reduced dependence on donor-blood logistics are core product-development objectives.
Cell-free architecture
One core Biological Hemoglobin Oxygen Carrier architecture designed for controlled oxygen delivery across blood-group systems, with species-specific evidence still required.
Development boundary
Open EvidenceProduct objectives are not regulatory approval.
BHOC development requires product-specific and species-specific evidence for formulation, dosing, safety and efficacy. Historical HBOC and Oxyglobin evidence is presented separately in the Evidence section.